Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells.

Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells.

Publication date: Mar 23, 2020

Epitopes derived from mutated cancer proteins elicit strong antitumor T-cell responses that correlate with clinical efficacy in a proportion of patients. However, it remains unclear whether the subcellular localization of mutated proteins influences the efficiency of T-cell priming. To address this question we compared the immunogenicity of NY-ESO-1 and OVA localized either in the cytosol or in mitochondria. We showed that tumors expressing mitochondrial-localized NY-ESO-1 and OVA proteins elicit significantly higher frequencies of antigen-specific CD8+ T cells in vivo. We also demonstrated that this stronger immune response is dependent on the mitochondrial location of the antigenic proteins, which contributes to their higher steady state amount, compared with cytosolic-localized proteins. Consistent with these findings, we showed that injection of mitochondria purified from B16 melanoma cells can protect mice from a challenge with B16 cells, but not with irrelevant tumors. Finally, we extended these findings to cancer patients by demonstrating the presence of T-cell responses specific for mutated mitochondrial-localized proteins. These findings highlight the utility of prioritizing epitopes derived from mitochondrial-localized mutated proteins as targets for cancer vaccination strategies.

Open Access PDF

Prota, G., Gileadi, U., Rei, M., Lechuga-Vieco, A.V., Chen, J.L., Galiani, S., Bedard, M., Lau, V.W.C., Fanchi, L.F., Artibani, M., Hu, Z., Gordon, S., Rehwinkel, J., Enr’iquez, J.A., Ahmed, A.A., Schumacher, T.N., and , Cerundolo. Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells. 26217. 2020 Cancer Immunol Res.

Concepts Keywords
Antigen Mitochondrion
Antigenic Proteins Cellular respiration
CD8 Mitochondria
Cytosol Immune system
Cytosolic Medicine
Epitopes Immunology
ESO Branches of biology
Immunogenicity Vaccination
Melanoma Tumors
Mitochondria B16 melanoma
Mitochondrial Cytosol
OVA Epitope
Priming Immunogen
Subcellular Localization Antigen
T Cell


Type Source Name
disease MESH cancer
drug DRUGBANK Esomeprazole
disease MESH B16 melanoma


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *